“PD-L1 Expression As a Predictor of Response to Neoadjuvant Immunotherapy in Triple-Negative Breast Cancer”. Journal of Evidence-Based Medical Research 2, no. 03 (September 1, 2026): 58–69. Accessed October 4, 2026. https://jebmr.com/index.php/home/article/view/43.